ArticleTransplantation and cellular therapy2021

Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell Transplantation.

Natasia Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.